Fetal or neonatal alloimmune thrombocytopenia (Q51687): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 22:53, 13 August 2026
fetal and neonatal alloimmune thrombocytopenia (NAIT) results from maternal alloimmunisation against fetal platelet antigens inherited from the father and different from those present in the mother, and usually presents as a severe isolated thrombocytopaenia in otherwise healthy newborns. NAIT has been considered to be the platelet counterpart of Rh Haemolytic Disease of the Newborn (RHD). Unlike RHD, NAIT can occur during a first pregnancy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1407651542 |
||
| English | Fetal or neonatal alloimmune thrombocytopenia |
fetal and neonatal alloimmune thrombocytopenia (NAIT) results from maternal alloimmunisation against fetal platelet antigens inherited from the father and different from those present in the mother, and usually presents as a severe isolated thrombocytopaenia in otherwise healthy newborns. NAIT has been considered to be the platelet counterpart of Rh Haemolytic Disease of the Newborn (RHD). Unlike RHD, NAIT can occur during a first pregnancy. |
Statements
CID11:ID_1407651542
0 references
dki-india-ID_1407651542
0 references
Concluído
0 references
13 August 2026
0 references
